Valuation: McKesson Corporation

Market Cap 94.36B 82.76B 76.65B 70.53B 133B 9,031B 136B 914B 358B 4,435B 354B 347B 15,317B P/E 2027 *
19.1x
P/E 2028 * 16.8x
Enterprise Value 99.16B 86.97B 80.55B 74.12B 140B 9,491B 143B 960B 377B 4,661B 372B 364B 16,096B EV / Sales 2027 *
0.23x
EV / Sales 2028 * 0.21x
Free-Float
42.23%
Yield 2027 *
0.41%
Yield 2028 * 0.44%
1 day+5.15%
1 week+3.55%
Current month+7.57%
1 month+4.38%
3 months-5.19%
6 months-2.26%
Current year-1.46%
1 week 784.5
Extreme 784.5
826.9
1 month 735
Extreme 735
826.9
Current year 710.01
Extreme 710.01
1,016.97
1 year 637.28
Extreme 637.285
1,016.97
3 years 397
Extreme 397
1,016.97
5 years 187.02
Extreme 187.0235
1,016.97
10 years 108.34
Extreme 108.34
1,016.97
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2019
Chief Tech/Sci/R&D Officer 53 03/10/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 75 01/04/2022
Director/Board Member 70 24/04/2018
Chairman 59 01/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
+3.84%+3.55% - - 94.36B
-0.91%-1.63%+44.51%+150.12% 55.23B
+3.55%+4.66%+2.10%+269.62% 22.56B
+1.24%+1.30%-14.05%-22.35% 8.01B
-0.75%-2.96%-27.34%-35.23% 7.6B
+0.72%+0.66%-10.56%-27.84% 6.66B
-1.55%-2.79%+20.94%+34.64% 6.25B
+0.81%+1.69%-1.69%+23.87% 5.36B
+1.00%+2.43%-5.24%-6.08% 3.68B
+0.95%+0.59%+12.25%+16.43% 3.34B
Average +1.05%+0.15%+2.32%+44.80% 13.19B
Weighted average by Cap. +2.48%-0.35%+19.03%+118.95%

Financials

2027 *2028 *
Net sales 431B 378B 350B 322B 610B 41,272B 621B 4,175B 1,637B 20,268B 1,619B 1,584B 69,994B 463B 407B 377B 346B 655B 44,361B 668B 4,488B 1,760B 21,785B 1,740B 1,702B 75,233B
Net income 4.93B 4.32B 4B 3.68B 6.96B 471B 7.1B 47.69B 18.71B 232B 18.5B 18.09B 800B 5.41B 4.75B 4.4B 4.05B 7.65B 518B 7.8B 52.41B 20.55B 254B 20.32B 19.88B 879B
Net Debt 4.8B 4.21B 3.9B 3.59B 6.79B 459B 6.92B 46.48B 18.23B 226B 18.03B 17.63B 779B 4.55B 3.99B 3.69B 3.4B 6.43B 435B 6.55B 44.02B 17.27B 214B 17.07B 16.7B 738B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
42,300
Date Price Change Volume
13/07/26 $812.89 +3.84% 22
10/07/26 $803.71 +1.80% 664
09/07/26 $789.50 -3.42% 476
08/07/26 $817.44 +1.58% 242
07/07/26 $804.69 +2.51% 309
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
805.96USD
Average target price
942.07USD
Spread / Average Target
+16.89%

Quarterly revenue - Rate of surprise